# MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/mTOR Signaling Pathway In Vivo and In Vitro

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mk-2206-alleviates-renal-fibrosis-by-suppressing-the-akt-mtor-signaling-pathway/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Meiling Chen,Yihang Yu,Tao Mi,Qitong Guo,Bin Xiang,Xiao‐Mao Tian,Liming Jin,Chunlan Long,Lianju Shen,Xing Liu,Jianbo Pan,Yuanyuan Zhang,Tao Xu,Deying Zhang,Guanghui Wei |
| Citations | 28 |
| DOI | 10.3390/cells11213505 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.mdpi.com/2073-4409/11/21/3505/pdf?version=1667971074 |
| OpenAlex ID | https://openalex.org/W4308455710 |
| PMID | 36359901 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Tao Mi](https://scholariq.org/researchers/tao-mi/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.